Ugro Capital GROx disburses ₹1,853 crore in Q1FY27

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Ugro Capital reported Q1FY27 net profit of ₹607 million, up 78% YoY, fueled by GROx platform disbursements of ₹1,853 crore. Total net disbursements rose 59% to ₹2,551 crore. Asset quality strengthened with Gross Stage 3 ratios declining, and cost optimization efforts reduced operating expenses by 42%.

powered bylight_fuzz_icon
46868674

*this image is generated using AI for illustrative purposes only.

Ugro Capital reported a 78% year-on-year surge in standalone net profit to ₹607 million for Q1FY27, driven by the rapid scaling of its embedded merchant finance platform, GROx. The non-banking financial company (NBFC) recorded revenue from operations of ₹4.2 billion, up from ₹4.1 billion in the corresponding period last year. This performance marks the first full quarter of execution following the strategic realignment announced in February 2026, which shifted focus toward higher-yielding, scalable lending verticals.

GROx Drives Disbursement Growth

The technology-led embedded merchant finance platform, GROx (formerly MyShubhLife), emerged as the primary growth engine, disbursing ₹1,853 crore in the quarter alone. With over 60,000 loans disbursed monthly, GROx’s asset under management (AUM) grew 32% quarter-on-quarter to ₹3,003 crore as of June 30, 2026. The portfolio maintains strong asset quality with a gross non-performing asset (GNPA) ratio of 2.1% and a yield of approximately 26%. Across the company, total net disbursements rose 59% year-on-year to ₹2,551 crore.

Metric: Q1FY27 Change
GROx Disbursements: ₹1,853 crore N/A
GROx AUM: ₹3,003 crore QoQ ↑ 32%
Total Net Disbursements: ₹2,551 crore YoY ↑ 59%

Emerging Market Network Stabilizes

Ugro Capital completed the build-out of its Emerging Market branch network, now comprising 317 branches across 13 states supported by more than 2,500 employees. No further incremental branch investments are planned, with future growth expected from improved productivity. Branch productivity is projected to rise from ₹0.62 crore in Q1FY27 to ₹0.80–0.85 crore as the network matures. The Emerging Market business disbursed ₹592 crore, taking its AUM to ₹3,896 crore, up 9% quarter-on-quarter, with a GNPA of 2.1%.

Asset Quality and Profitability

Asset quality strengthened sequentially, with the Gross Stage 3 ratio declining to 2.75% from 3.66%, and the Net Stage 3 ratio improving to 1.71% from 2.24%. Overall GNPA remained stable at 2.6%. Profit Before Tax (PBT) increased 28% year-on-year to ₹61.5 crore. Return on Assets (ROA) improved to 2.8% from 2.1% in Q4FY26, while Return on Equity (ROE) rose to 9.2% from 7.1%. The company maintains a robust balance sheet with a Capital to Risk-Weighted Assets Ratio (CRAR) of 21.0% and cash reserves of ₹1,864 crore.

Strategic Realignment Progress

The company has fully achieved its planned ₹220 crore annualised cost optimisation, with quarterly operating expenses falling 42% to ₹118.5 crore. The lower-yielding Prime lending portfolio reduced by 14% during the quarter. Together, Emerging Market LAP and GROx now constitute 46% of the total AUM mix, up from 32% in December 2025, moving toward an 85% target by FY29. Ugro Capital expects no requirement for additional equity through FY29, aiming for a steady-state ROA of 3.0–3.5% by FY29.

What the Numbers Show

The divergence between stable total AUM (up 24% YoY to ₹15,013 crore) and surging profitability highlights the success of the portfolio mix shift. While overall AUM growth is moderate, the transition from lower-yield Prime loans to higher-yield GROx and Emerging Market loans has expanded margins significantly. The 42% drop in operating expenses alongside a 28% rise in PBT demonstrates that the cost optimization measures are directly translating into bottom-line gains, validating the shift toward an annuity-led earnings model.

Historical Stock Returns for UGRO Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+1.96%-3.96%-9.27%-24.64%-47.38%-29.43%

How might the aggressive shift toward higher-yield GROx and Emerging Market loans impact Ugro Capital's credit risk profile as it approaches its 85% AUM mix target by FY29?

With branch expansion halted, what specific operational strategies or technological interventions will Ugro Capital employ to achieve the projected jump in branch productivity from ₹0.62 crore to ₹0.85 crore?

Given the reliance on GROx for growth, how vulnerable is Ugro Capital to potential regulatory changes in the embedded finance or NBFC sector that could affect merchant lending practices?

Ugro Capital records highest monthly disbursement of over ₹1,000 crores in July 2026

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Ugro Capital Limited disclosed a record monthly disbursement of over ₹1,000 crores for July 2026, marking a significant operational milestone. This achievement highlights the effectiveness of its diversified distribution strategy through Emerging Markets and Embedded Finance verticals.

powered bylight_fuzz_icon
47283290

*this image is generated using AI for illustrative purposes only.

ugro capital has achieved a significant operational milestone by recording its highest-ever monthly disbursement of over ₹1,000 crores in July 2026. The company disclosed this achievement on August 3, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This surge in lending activity underscores the effectiveness of Ugro Capital’s diversified distribution strategy, particularly highlighting the combined contributions from its Emerging Markets branch network and its Embedded Finance business. For investors, this metric signals robust demand for the company’s lending products and validates its ability to scale operations efficiently across different customer segments.

The disclosure was made to ensure uniform and simultaneous dissemination of information to all shareholders and investors. Management noted that the company plans to celebrate this milestone internally across its branch network and offices. As part of these celebrations, employees, business partners, and other stakeholders may share related content on various social media platforms. To prevent any information asymmetry, Ugro Capital issued this regulatory filing prior to such internal communications.

Operational Drivers

The record disbursement figure is not attributed to a single vertical but reflects a balanced growth trajectory across key business units. The Emerging Markets branch network continues to expand its reach into new geographies, while the Embedded Finance business integrates lending solutions directly into partner ecosystems. This dual-engine approach allows the company to mitigate concentration risk and tap into diverse borrower profiles.

Parameter: Details
Milestone: Highest Ever Monthly Disbursement
Amount Surpassed: ₹1,000 Crores
Period: July 2026
Key Drivers: Emerging Markets Branch Network, Embedded Finance Business

Strategic Implications

This achievement reinforces Ugro Capital’s position as a growing player in the non-banking financial company (NBFC) sector. The ability to disburse over ₹1,000 crores in a single month demonstrates strong operational capacity and credit underwriting capabilities. It also suggests that the company’s recent strategic initiatives to diversify distribution channels are yielding tangible results. Investors should monitor subsequent months to see if this level of disbursement can be sustained, which would indicate a structural shift in the company’s growth profile rather than a one-off spike.

The filing confirms that the company remains compliant with regulatory norms while executing its growth strategy. By proactively disclosing this positive development, management aims to maintain transparency with the investing public. This milestone serves as a key performance indicator for the company’s lending book expansion and overall market penetration efforts.

Historical Stock Returns for UGRO Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+1.96%-3.96%-9.27%-24.64%-47.38%-29.43%

Can Ugro Capital sustain the ₹1,000 crore monthly disbursement run rate in subsequent quarters, or is this a seasonal anomaly?

How will the rapid expansion of the Emerging Markets branch network impact the company's cost-to-income ratio and operational efficiency?

What are the projected asset quality trends and non-performing asset (NPA) ratios given the accelerated growth in lending volumes?

More News on UGRO Capital

1 Year Returns:-47.38%